Involving of the cytoplasmic region of leukemia inhibitory factor receptor α subunit, IL-6 related signal transducer-gp130 or Fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG

Molecular and Cellular Biochemistry

Volumn 217, Issue 1-2, 2001, Pages 113-120

  Liu, Houqi ^a   Dan, Jikuan ^a   Tang, Shuping ^a   Wu, Shaorong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell strains; Leukemia; LIF; MAPK; Receptor

Indexed keywords

CHIMERIC PROTEIN; FAS ANTIGEN; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN G; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; LEUKEMIA INHIBITORY FACTOR RECEPTOR BETA; LIPOFECTAMINE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P44; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOPLASM; DIMERIZATION; ENZYME PHOSPHORYLATION; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; OLIGOMERIZATION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ANTIGENS, CD95; CELL DIVISION; CYTOKINE RECEPTOR GP130; CYTOPLASM; DIMERIZATION; ENZYME ACTIVATION; GROWTH INHIBITORS; HL-60 CELLS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0035125681     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007220627845     Document Type: Article

References (35)

1. LIF: Lots of interesting functions
2. The IL-6 signal transducer, gp 130: An oncostatin M receptor and affinity converter for the LIF receptor
3. CNTF and LIF act on neuronal cell via shared signaling pathways that involve the IL-6 signal transducing receptor component gp 130
4. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp 130
5. Oncostatin M regulates VIP expression in a human neuroblastoma cell line
6. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the IL-6 signal transducer gp130
7. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6
8. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp 130 in cardiac myocytes
9. Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells
10. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family
11. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta-receptor components
12. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
13. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor and gp130 cooperate in signal transduction in hepatic and neuronal cells
14. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation
15. Box3-independent signal mechanisms are involved in leukemia inhibitory factor receptor α- and gp130-mediated stimulation of mitogen-activated kinase
16. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors
17. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation
18. Distinct roles for leukemia inhibitory factor α-chain and gp130 in cell type-specific signal transduction
19. The polypeptide encodes by the cDNA for human cell surface antigen Fas can mediate apoptosis
20. Molecular cloning and expression of the Fas ligand, a novel member of the TNF family
21. Expression of the functional soluble form of human the Fas ligand in activated lymphocytes
22. Monoclonal antibody-mediated tumor regression by induction of apoptosis
23. Swapping between Fas and granulocyte colony-stimulating factor receptor
24. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
25. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
26. Cloning and expression of leukemia inhibitory factor in CHO cell line and its inhibitory effect on the proliferation of U937
27. Colonial suppression of HL60 and U937 cells by recombinant leukemia inhibitory factor in combination with GM-CSF or G-CSF leukemia
28. Signaling by the homomerization of the cytoplasmic domain of leukemia inhibitory factor (LIF) receptor a subunit or IL-6 related signal transducer-gp130 and by the oligomerization of Fas death domain for Stat3 or anti-Fas antibody stimulation on HL-60 cell
29. Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukemia inhibitory factor. Evidence for participation of multiple signaling pathways
30. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
31. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
32. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death
33. Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas
34. Tumor necrosis factor receptor and Fas signaling mechanisms
35. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines